What Are Semaglutides? Breaking Down the Buzzword
Wondering what semaglutides are? Get a simple breakdown of the medications, how they work, and how Eden connects you to licensed providers for evaluation.
Thinking about GLP1 medication? Here are key questions to consider before speaking with a licensed provider about your options.
This content is for informational purposes only and does not constitute medical advice. Medications like semaglutide are only prescribed when clinically appropriate and are dispensed through state-licensed pharmacies. Eden is not a pharmacy or healthcare provider.
GLP1 medications like semaglutide have become widely discussed for their role in supporting metabolic health. But before starting any new treatment, especially one that affects critical systems like appetite regulation and blood sugar, it’s essential to understand how it works, whether it’s appropriate for you, and what to expect.
If you’re considering a GLP1 medication and want to make an informed decision, asking the right questions can help guide your conversation with a licensed healthcare provider. This article highlights the most important things to consider before beginning treatment, from eligibility to safety to long-term care.
GLP1 stands for glucagon-like peptide-1, which is a hormone the body produces naturally. It helps regulate blood sugar, slows digestion, and plays a role in appetite signaling. A GLP1 medication is a prescription treatment that mimics this hormone’s action in the body.
Some GLP1 medications, such as semaglutide (available under brand names like Ozempic®, Wegovy®, and Rybelsus®), have received FDA approval for specific conditions, including type 2 diabetes (Ozempic® and Rybelsus®) and chronic weight management (Wegovy®) in individuals who meet medical criteria. Others, including Mounjaro® and Zepbound® (tirzepatide), act on both the GLP1 and GIP receptors and are FDA-approved for specific indications related to type 2 diabetes and chronic weight management, respectively.
The decision to prescribe a GLP1 medication depends entirely on a licensed healthcare provider’s evaluation of your health profile.
{{primary-cta}}
Before starting a GLP1 medication, it’s important to ask questions that clarify whether it’s clinically appropriate, how the treatment works, and what ongoing care may be needed. Here are some key questions to consider bringing to your provider:
Asking these questions can help ensure that your care is grounded in clinical evidence and tailored to your specific health needs.
No. While many GLP1 medications interact with similar biological pathways, they differ in their active ingredients, FDA-approved uses, and how they are administered.
For example:
When evaluating any GLP1 treatment program, consider the following:
{{primary-cta}}
A GLP1 medication is only prescribed after a clinical consultation with a licensed healthcare provider. This may include:
If the provider determines a GLP1 is appropriate, they will issue a prescription to a state-licensed pharmacy that dispenses the medication. Some patients may begin at a lower dose and increase over time, depending on how they respond.
On the Eden platform, independent licensed healthcare providers handle all treatment decisions. Eden does not prescribe or distribute medication.
Ongoing support may be an important part of treatment. Patients may benefit from:
GLP1 medications are not quick fixes. They are part of a broader strategy that may include sustainable behavior change and long-term provider oversight.
Patients who have success with GLP1 treatment often engage in structured care models that help them stay accountable and supported. Always ask what kind of follow-up care is included with any program you consider.
{{primary-cta}}
If you’re comparing programs that offer access to GLP1 medications, consider the following:
Avoid programs that promise fast results or advertise GLP1s without making it clear that a medical evaluation is required. Medications that are not approved by the FDA or sourced from unregulated pharmacies can pose serious risks.
Eden is a digital platform that connects patients to independent licensed healthcare providers. These providers evaluate your medical history, order labs if needed, and determine whether a GLP1 medication is appropriate for you.
Through Eden, patients may access:
Eden does not make, prescribe, or dispense medications. Its role is to provide access to medical expertise and support your journey toward improved metabolic health through safe, clinically guided care.
GLP1 medications are one tool in the broader landscape of metabolic care, but they require thoughtful consideration and medical oversight. Asking the right questions can help you understand your options and feel confident about the steps ahead.
If you’re ready to explore whether a GLP1 medication may be right for you, Eden makes it easy to connect with independent, licensed healthcare providers who can offer guidance based on your unique health needs.
Start your metabolic health journey with confidence – Connect with a licensed healthcare provider today.
Disclaimer: The FDA does not approve compounded medications for safety, quality, or manufacturing. Prescriptions and a medical evaluation are required for certain products. The information provided on this blog is for general informational purposes only. It is not intended as a substitute for professional advice from a qualified healthcare professional and should not be relied upon as personal health advice. The information contained in this blog is not meant to diagnose, treat, cure, or prevent any disease. Readers are advised to consult with a qualified healthcare professional for any medical concerns, including side effects. Use of this blog's information is at your own risk. The blog owner is not responsible for any adverse effects or consequences resulting from the use of any suggestions or information provided in this blog.
Eden is not a medical provider or a pharmacy. Eden connects individuals with independent licensed healthcare providers who independently evaluate each patient to determine whether a prescription treatment program is appropriate. All prescriptions are written at the sole discretion of the licensed provider. Medications are filled by independent, state-licensed pharmacies. Eden does not manufacture, own, or dispense any medications. Please consult a licensed healthcare provider before making any medical decisions.
ClinicalTrials.gov. (n.d.). https://clinicaltrials.gov/study/NCT04184622
Davies, M., Færch, L., Jeppesen, O. K., Pakseresht, A., Pedersen, S. D., Perreault, L., Rosenstock, J., Shimomura, I., Viljoen, A., Wadden, T. A., & Lingvay, I. (2021). Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet, 397(10278), 971–984. https://doi.org/10.1016/s0140-6736(21)00213-0
Frías, J. P., Davies, M. J., Rosenstock, J., Manghi, F. C. P., Landó, L. F., Bergman, B. K., Liu, B., Cui, X., & Brown, K. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/nejmoa2107519
Wilding, J. P. H., Batterham, R. L., Davies, M., Van Gaal, L. F., Kandler, K., Konakli, K., Lingvay, I., McGowan, B. M., Oral, T. K., Rosenstock, J., Wadden, T. A., Wharton, S., Yokote, K., & Kushner, R. F. (2022). Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes Obesity and Metabolism, 24(8), 1553–1564. https://doi.org/10.1111/dom.14725